Imexpharm Market Cap

Imexpharm has a market cap or net worth of 7.32 trillion as of April 28, 2026. Its market cap has increased by 20.41% in one year.

Market Cap

7.32T

Enterprise Value

7.05T

Revenue

2.39T

Ranking

n/a

PE Ratio

23.51

Stock Price

47,500.00

Market Cap Chart

Since April 2, 2007, Imexpharm's market cap has increased from 1.11T to 7.32T, an increase of 559.76%. That is a compound annual growth rate of 10.39%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	7,315.43B	-9.52%
Dec 31, 2025	8,085.47B	11.70%
Dec 31, 2024	7,238.42B	82.69%
Dec 29, 2023	3,962.17B	-1.28%
Dec 30, 2022	4,013.63B	-22.62%
Dec 31, 2021	5,187.05B	38.19%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ha Tay Pharmaceutical JSC	6,340.18B
Binh Dinh Pharmaceutical and Medical Equipment JSC	4,700.84B
DHG Pharmaceutical JSC	13.01T
Traphaco JSC	3,166.82B
Cuu Long Pharmaceutical JSC	2,724.43B
Domesco Medical Import - Export Joint-Stock	2,048.92B
OPC Pharmaceutical JSC	1,434.74B
Central Pharmaceutical Joint Stock Company No3	1,249.15B

Market Cap Rankings